Michael D. Clayman, MD
Michael D. Clayman, MD, is chief executive officer and co-founder, Flexion Therapeutics.
Articles
New content coming soon.
Latest Updated Articles
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: September 10th 2024 | Updated: September 12th 2024
Deepak Bhatt, MD, MPH, MBA: SGLT2 Offers Kidney Protective Benefit in Post-MI Population
Published: October 9th 2014 | Updated: September 12th 2024
Widespread "Yellow Bumps"
Published: September 6th 2024 | Updated: September 12th 2024
Collaboration and Communication Across the Healthcare Team
Published: September 6th 2024 | Updated: September 12th 2024
Treatment-Emergent Hypophosphatemia Following Administration of Intravenous Iron
Published: September 9th 2024 | Updated: September 12th 2024
Upper GI Mucosal Damage Linked to Increased Risk of Parkinson Disease
